| Literature DB >> 25911237 |
Olga N Kuvardina1, Julia Herglotz2, Stephan Kolodziej1, Nicole Kohrs1, Stefanie Herkt1, Bartosch Wojcik3, Thomas Oellerich4, Jasmin Corso5, Kira Behrens2, Ashok Kumar1, Helge Hussong1, Henning Urlaub5, Joachim Koch1, Hubert Serve4, Halvard Bonig6, Carol Stocking2, Michael A Rieger7, Jörn Lausen1.
Abstract
The activity of antagonizing transcription factors represents a mechanistic paradigm of bidirectional lineage-fate control during hematopoiesis. At the megakaryocytic/erythroid bifurcation, the cross-antagonism of krueppel-like factor 1 (KLF1) and friend leukemia integration 1 (FLI1) has such a decisive role. However, how this antagonism is resolved during lineage specification is poorly understood. We found that runt-related transcription factor 1 (RUNX1) inhibits erythroid differentiation of murine megakaryocytic/erythroid progenitors and primary human CD34(+) progenitor cells. We show that RUNX1 represses the erythroid gene expression program during megakaryocytic differentiation by epigenetic repression of the erythroid master regulator KLF1. RUNX1 binding to the KLF1 locus is increased during megakaryocytic differentiation and counterbalances the activating role of T-cell acute lymphocytic leukemia 1 (TAL1). We found that corepressor recruitment by RUNX1 contributes to a block of the KLF1-dependent erythroid gene expression program. Our data indicate that the repressive function of RUNX1 influences the balance between erythroid and megakaryocytic differentiation by shifting the balance between KLF1 and FLI1 in the direction of FLI1. Taken together, we show that RUNX1 is a key player within a network of transcription factors that represses the erythroid gene expression program.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25911237 PMCID: PMC4463808 DOI: 10.1182/blood-2014-11-610519
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113